Cohance Lifesciences Limited logo

Cohance Lifesciences Limited (COHANCE)

Market Closed
13 Aug, 22:00
MSE MSE
444. 65
+0.15
+0.0337%
- Market Cap
- P/E Ratio
- Div Yield
26,826 Volume
- Eps
444.5
Previous Close
Add Transaction
Day Range
441.35 452
Year Range
267.85 1,038
Want to track COHANCE and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

COHANCE closed today higher at ₹444.65, an increase of 0.0337% from yesterday's close, completing a monthly decrease of -2.6065% or -₹11.9. Over the past 12 months, COHANCE stock lost -15.9849%.
COHANCE is not paying dividends to its shareholders.
The last earnings report, released on May 26, 2026, exceeded the consensus estimates by 0%. On average, the company has surpassed earnings expectations by 0%, based on the last three reports.
Cohance Lifesciences Limited has completed 1 stock splits, with the recent split occurring on Sep 25, 2020.
The company's stock is traded on 2 different exchanges and in various currencies, with the primary listing on XNSE (INR).

COHANCE Chart

Cohance Lifesciences Limited (COHANCE) FAQ

What is the stock price today?

The current price is ₹444.65.

On which exchange is it traded?

Cohance Lifesciences Limited is listed on MSE.

What is its stock symbol?

The ticker symbol is COHANCE.

Does it pay dividends? What is the current yield?

It does not pay dividends to its shareholders.

What is its market cap?

As of today, no market cap data is available.

Has Cohance Lifesciences Limited ever had a stock split?

Cohance Lifesciences Limited had 1 splits and the recent split was on Sep 25, 2020.

Cohance Lifesciences Limited Profile

- Industry
- Sector
- CEO
MSE Exchange
INE03QK01018 ISIN
India Country
1,212 Employees
- Last Dividend
25 Sep 2020 Last Split
- IPO Date

Overview

Cohance Lifesciences Limited, established in 1989 and headquartered in Hyderabad, India, is a prominent contract development and manufacturing organization (CDMO) with a focus on the pharmaceutical and chemical sectors. The company specializes in the development and manufacturing of new chemical entity (NCE) based intermediates, active pharmaceutical ingredients (APIs), specialty chemicals, and formulated drugs. As a subsidiary of Berhyanda Limited since its rebranding from Suven Pharmaceuticals Limited in May 2025, Cohance Lifesciences has expanded its international reach, serving significant markets in India, the United States, and Europe. The organization is dedicated to supporting the entire drug development lifecycle, from initial process research to late-stage clinical and commercial manufacturing, thereby playing a pivotal role in pharmaceutical innovation and manufacturing efficiency.

Products and Services

  • Small Molecule APIs

    Cohance manufactures high-quality small molecule active pharmaceutical ingredients, which are essential for various therapeutic applications and are produced under stringent quality standards.

  • Advanced Intermediates

    The company develops advanced intermediates that serve as crucial building blocks in the synthesis of complex pharmaceutical products, enhancing the efficiency of drug formulation.

  • Antibody Drug Conjugates

    Cohance specializes in the production of antibody drug conjugates, which offer targeted cancer therapies by combining potent cytotoxic drugs with monoclonal antibodies.

  • High-Purity Oligonucleotide Building Blocks

    Providing high-purity oligonucleotide building blocks, the company supports the synthesis of nucleotides for various applications in molecular biology and therapeutic development.

  • Finished Dosage Forms

    Cohance offers a range of formulated drugs in finished dosage forms, ensuring supply chain efficiency and compliance with international regulatory standards.

  • Specialty Agrochemicals

    In addition to pharmaceuticals, the company develops specialty agrochemicals aimed at improving agricultural practices and enhancing crop productivity.

Contact Information

Address: A-Wing, Galaxy Towers
Phone: 91 40 2354 9414